Study of SNX-5422 in TP53 Null Cancers
Clinical trial NCT02612285 · TERMINATED
Trial details
- NCT number
- NCT02612285
- Sponsor
- Esanex Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2016-10-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.